You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
NEW YORK – Clinical stage biotechnology company Tiziana Life Sciences said on Wednesday it plans to spin off its StemPrintER asset into a separate and independently listed public company called Accustem Sciences.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.